Association between Lipid Levels, Anti-SARS-CoV-2 Spike Antibodies and COVID-19 Mortality: A Prospective Cohort Study.

Mink, Sylvia; Saely, Christoph H; Frick, Matthias; Leiherer, Andreas; Drexel, Heinz; Fraunberger, Peter

Mink, Sylvia; Saely, Christoph H; Frick, Matthias; Leiherer, Andreas; Drexel, Heinz; Fraunberger, Peter.

Afiliação

Mink S; Central Medical Laboratories, 6800 Feldkirch, Austria.
Saely CH; Medical-Scientific Faculty, Private University of the Principality of Liechtenstein, 9495 Triesen, Liechtenstein.
Frick M; Medical-Scientific Faculty, Private University of the Principality of Liechtenstein, 9495 Triesen, Liechtenstein.
Leiherer A; VIVIT Institute, Academic Teaching Hospital Feldkirch, 6800 Feldkirch, Austria.
Drexel H; Department of Internal Medicine, Academic Teaching Hospital Feldkirch, 6800 Feldkirch, Austria.
Fraunberger P; Central Medical Laboratories, 6800 Feldkirch, Austria.

J Clin Med ; 12(15)2023 Aug 01.

Article em En | MEDLINE | ID: mdl-37568470

Palavras-chave

COVID-19; HDL-C; LDL-C; SARS-CoV-2; anti-SARS-CoV-2 antibodies; in-hospital mortality; lipid profile; total cholesterol; triglycerides

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google